FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
Post-bronchodilator response (PBDR) evaluated by plethysmographic and spirometric target parameters in patients with COPD, asthma-COPD-overlap (ACO) and asthma Source: International Congress 2018 – Innovations in equipment and their application Year: 2018
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Small airways disease evaluation in healthy smokers with normal spirometry values Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
Analysis of breathing acoustic parameters in patients with COPD, interstitial lung diseases and normal subjects Source: Annual Congress 2006 - Assessing the lungs in obstruction: technological advances in lung function testing Year: 2006
The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003
Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 338s Year: 2004
Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015
Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry? Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children Year: 2018
Respiratory system input impedance: correlation with spirometric values and lung volumes in healthy children Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
SPECT measurement of perfused lung volume in patients with COPD, patients with restrictive lung disease and healthy volunteers Source: Annual Congress 2010 - Infection, inflammation and destruction Year: 2010
Interpretation of spirometric data of 799 pulmonary male patients by ECCS/ERS and GLI-2012 reference values Source: International Congress 2016 – Quality and quantity in lung function Year: 2016
Repeatability of spirometry parameter in patients with chronic pulmonary diseases Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Measurement duration impacts variability but not impedance measured by the forced oscillation technique in healthy, asthma and COPD subjects Source: ERJ Open Res 2016: 00094-2015 Year: 2016
Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
Evaluation of respiratory movements of pharynx and trachea in patients with COPD and in healthy subjects by cine-MRI and lung function tests Source: Annual Congress 2004 - Recent advances in modern chest imaging and their implications on various clinical problems Year: 2004
Repeatability and reproducibility of impulse oscillometry and body plethysmography in healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation Year: 2013
Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD Source: Eur Respir J 2004; 24: 332 Year: 2004
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Respiratory impedance in healthy subjects: baseline values and bronchodilator response Source: Eur Respir J 2013; 42: 1513-1523 Year: 2013